This company has shut down. Syntach is no longer operating — its last tracked round was a Private Equity in 2023.
Explore the Startup GraveyardSyntach develops a cardiac support device to improve the care of the rapidly-growing number of people with heart failure.
Syntach has raised $16.3M in total funding. The most recent round was Private Equity. The last funding was announced in January 2023.
Syntach's investors include European Innovation Council.
Syntach is headquartered in Lund, Sweden.
Syntach develops a cardiac support device to improve the care of the rapidly-growing number of people with heart failure.
Syntach is at the Private Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Syntach — Funding & Investors." VCBacked, January 30, 2023, https://www.vcbacked.co/company/syntach. Accessed July 19, 2026.
VCBacked. (2023). Syntach — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/syntach
{{cite web |title=Syntach — Funding & Investors |url=https://www.vcbacked.co/company/syntach |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated